Appointment of Joint Corporate Broker

Summary by AI ^BETAClose X

Porvair plc has announced the immediate appointment of Deutsche Numis as its Joint Corporate Broker, who will collaborate with existing broker Peel Hunt LLP to enhance the company's investor engagement and capital markets activities. This strategic move aims to bolster Porvair's presence and communication within the financial community.

Disclaimer*

Porvair PLC

28 April 2026

Description: porvair logo

Porvair plc

("Porvair" or the "Group" or the "Company")

Appointment of Joint Corporate Broker

Porvair plc, the specialist filtration, laboratory and environmental technology group, announces the appointment of Deutsche Numis as the Company's Joint Corporate Broker with immediate effect.

Deutsche Numis will work alongside Peel Hunt LLP, the Company's existing Corporate Broker, to support the Company's investor engagement and capital markets activities.

For further information, please contact:

Porvair plc	+44 (0)1553 765 500
Hooman Caman Javvi, Chief Executive Officer
James Mills, Group Finance Director

Alma Strategic Communications	+44 (0)20 3405 0205
Andrew Jaques / Josh Royston / Hannah Campbell / Rose Docherty

Notes to editors

Porvair is a group of specialist filtration, laboratory and environmental technology companies. Our businesses design and manufacture bespoke consumable filtration products that are used in a range of niche markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END